Skip to main content
. 2022 Jul 27;8(8):1381–1407. doi: 10.1021/acsinfecdis.2c00253

Figure 3.

Figure 3

Clinically used lipoglycopeptide antibiotics. Structural differences of telavancin and oritavancin compared to vancomycin are indicated in blue. Structural differences of dalbavancin compared to teicoplanin are indicated in green. The amino acids of the peptides are numbered in orange, starting at the N-terminus.